Patients with advanced disease (Binet C) exhibited significantly higher PIM2 transcript and protein levels, and higher PIM1 protein expression than CLL patients at earlier stages (Binet A/B; Figure 1A, Figure S2A). This evidence concerns the gene PIM2 and B-cell chronic lymphocytic leukemia.